Dhuwit awis perusahaan: Ionis Pharmaceuticals (IONS)

IONS (Ionis) - tandha merek perusahaan

Ionis Pharmaceuticals (IONS) relies critically on external contractors for production and testing, yet a diversified supplier network eliminates logistics disruptions. The cash liquidity metric demonstrates stabilizing cash flows, with the figure standing at 1.88. Business resilience is bolstered by investments in cutting-edge laboratories to retain leading RNA therapy research scientists.

Ionis Pharmaceuticals, Inc. - Gunggung dana dhuwit perusahaan IONS (periode 04.07.2022 - 21.11.2026)

Rincian metrik lan analitis perusahaan Ionis (IONS)

- indikator kapitalisasi bursa perusahaan:
Analisis komprehensif perusahaan:IONS Ionis Pharmaceuticals
Produk merek ionispharma.com

Ionis Pharmaceuticals (IONS) holds a leading position in the high-margin RNA therapeutics segment, developing revolutionary methods to combat genetic pathologies. This metric measures the volume of liquid assets on account, determining the company's ability to generate interest income and maintain financial stability. An analysis of the enterprise's cash assets allows for an assessment of the balance between accumulating reserves and investing in the commercial development of drugs. Stable growth in liquidity confirms the issuer's long-term solvency.

Perusahaan pesaing

Volume dana dhuwit perusahaan TEM|QGEN - Cadangan dhuwit perusahaan|Dana dhuwit perusahaan Repligen RGEN|RNA: Dhuwit awis lan setara dhuwit awis perusahaan|CRSP: Dhuwit awis perusahaan|GeneDx Corp (WGS) - Dhuwit awis perusahaan|RARE: Volume dana dhuwit perusahaan|BEAM - Aset likuid perusahaan|SRPT (Sarepta Therapeutics) - Volume dana dhuwit perusahaan|Dhuwit awis perusahaan Twist Bioscience Inc (TWST)|Volume dana dhuwit perusahaan TXG|Aset likuid perusahaan Intellia|Stoke - Dhuwit awis perusahaan|BLFS: Dhuwit awis lan setara dhuwit awis perusahaan|Wave Life Sciences Corp - Volume dana dhuwit perusahaan|Maze Therapeutics, Inc. (MAZE) - Dhuwit awis perusahaan|Sionna Therapeutics Inc (SION) - Dana dhuwit perusahaan|Dhuwit awis perusahaan Prime Medicine Corp|Dana dhuwit perusahaan tayshagtx.com|QURE - Posisi dhuwit perusahaan|Dhuwit awis perusahaan MGTX (MeiraGTx Holdings plc)|REGENXBIO (RGNX) - Posisi dhuwit perusahaan|Volume dana dhuwit perusahaan SLDB (Solid Biosciences Inc.)|Sisa dhuwit perusahaan OCGN|PacBio Corp - Volume dana dhuwit perusahaan|Benitec Biopharma Inc. (BNTC) - Dhuwit awis perusahaan|DSGN: Volume dana dhuwit perusahaan|Dhuwit awis lan setara dhuwit awis perusahaan RCKT|Dhuwit awis perusahaan FDMT|Dhuwit awis lan setara dhuwit awis perusahaan LXEO (Lexeo Therapeutics)|Volume dana dhuwit perusahaan KRRO|Editas Medicine, Inc. - Dhuwit awis lan setara dhuwit awis perusahaan|Dana dhuwit perusahaan Silence Therapeutics Inc. SLN|Volume dana dhuwit perusahaan ProQR Therapeutics N.V. PRQR|CDXS: Dhuwit awis perusahaan|Posisi dhuwit perusahaan Sangamo (SGMO)|NAUT (Nautilus Bio) - Dhuwit awis perusahaan|MGX - Aset likuid perusahaan|DTIL (Precision BioSciences Inc.) - Volume dana dhuwit perusahaan|generationbio.com (GBIO) - Aset likuid perusahaan|Dana dhuwit perusahaan Boundless Bio Inc (BOLD)|Volume dana dhuwit perusahaan Exicure Inc. (XCUR)|Dana dhuwit perusahaan imunon.com IMNN|Volume dana dhuwit perusahaan Phio Pharmaceuticals PHIO|Mustang Bio Inc - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan transcodetherapeutics.com|BNGO: Volume dana dhuwit perusahaan|Dhuwit awis lan setara dhuwit awis perusahaan APDN|BLUE (bluebirdbio.com) - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan ImmunoPrecise Antibodies IPA|Dhuwit awis perusahaan OMGA (omegatherapeutics.com)|Volume dana dhuwit perusahaan Singular Genomics Systems, Inc. (OMIC)|Volume dana dhuwit perusahaan RGLS (Regulus Therapeutics, Inc.)|Volume dana dhuwit perusahaan Syros SYRS|Telesis Bio, Inc. - Volume dana dhuwit perusahaan|TRACON Pharmaceuticals (TCON) - Dhuwit awis perusahaan|UBX: Volume dana dhuwit perusahaan